{"id":6725,"date":"2025-02-07T13:12:53","date_gmt":"2025-02-07T13:12:53","guid":{"rendered":"https:\/\/stoxpo.com\/?p=6725"},"modified":"2025-02-07T13:12:54","modified_gmt":"2025-02-07T13:12:54","slug":"conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/","title":{"rendered":"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Collaboration Shifts Focus to Personalized Software Dashboards for Enhanced Efficiency<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Conduit Pharmaceuticals (CDT) announced the successful completion of Phase I in its AI-driven drug development collaboration with Sarborg Limited. With all milestones achieved, the partnership is now transitioning to Phase II, which will focus on developing personalized software dashboards to improve operational efficiency and decision-making.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Phase I, initiated in December 2024, laid the groundwork for integrating AI and cybernetics into Conduit\u2019s drug development process. It involved aligning Sarborg\u2019s AI-driven processes with Conduit\u2019s portfolio needs, validating proprietary inputs, and conducting an in-depth market analysis of cocrystal candidates. The phase also established key algorithmic approaches aimed at optimizing drug repurposing, discovery, and clinical trial monitoring.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The transition to Phase II marks a strategic shift toward technological infrastructure development. Conduit and Sarborg will create AI-powered dashboards to provide real-time insights into clinical trials, drug discovery, and portfolio management. These tools are expected to enhance agility in decision-making and improve operational oversight, particularly in advancing treatments for autoimmune disorders.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With this next phase, Conduit continues its commitment to leveraging AI for innovation in drug development, aiming to optimize efficiency and accelerate the path to new therapies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/finance.yahoo.com\/news\/conduit-pharmaceuticals-transitions-phase-ii-130000318.html\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Read original press release here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/teslas-china-sales-drop-in-january-as-byd-gains-ground\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Tesla\u2019s China Sales Drop in January as BYD Gains Ground<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Collaboration Shifts Focus to Personalized Software Dashboards for Enhanced Efficiency Conduit Pharmaceuticals (CDT) announced the successful completion of Phase I in its AI-driven drug development collaboration with Sarborg Limited. With all milestones achieved, the partnership is now transitioning to Phase II, which will focus on developing personalized software dashboards to improve operational efficiency and decision-making. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1142,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"0","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"0","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[309,359],"tags":[638,637,421,416,418],"coauthors":[453],"class_list":["post-6725","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceuticals","category-small-cap","tag-cdt","tag-conduit","tag-growth","tag-movers","tag-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Collaboration Shifts Focus to Personalized Software Dashboards for Enhanced Efficiency Conduit Pharmaceuticals (CDT) announced the successful completion of Phase I in its AI-driven drug development collaboration with Sarborg Limited. With all milestones achieved, the partnership is now transitioning to Phase II, which will focus on developing personalized software dashboards to improve operational efficiency and decision-making. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T13:12:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-07T13:12:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development\",\"datePublished\":\"2025-02-07T13:12:53+00:00\",\"dateModified\":\"2025-02-07T13:12:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/\"},\"wordCount\":226,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"keywords\":[\"CDT\",\"Conduit\",\"Growth\",\"Movers\",\"News\"],\"articleSection\":[\"Pharmaceuticals\",\"Small-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/\",\"name\":\"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"datePublished\":\"2025-02-07T13:12:53+00:00\",\"dateModified\":\"2025-02-07T13:12:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/07\\\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development - Stoxpo","og_description":"Collaboration Shifts Focus to Personalized Software Dashboards for Enhanced Efficiency Conduit Pharmaceuticals (CDT) announced the successful completion of Phase I in its AI-driven drug development collaboration with Sarborg Limited. With all milestones achieved, the partnership is now transitioning to Phase II, which will focus on developing personalized software dashboards to improve operational efficiency and decision-making. [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/","og_site_name":"Stoxpo","article_published_time":"2025-02-07T13:12:53+00:00","article_modified_time":"2025-02-07T13:12:54+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development","datePublished":"2025-02-07T13:12:53+00:00","dateModified":"2025-02-07T13:12:54+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/"},"wordCount":226,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","keywords":["CDT","Conduit","Growth","Movers","News"],"articleSection":["Pharmaceuticals","Small-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/","url":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/","name":"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","datePublished":"2025-02-07T13:12:53+00:00","dateModified":"2025-02-07T13:12:54+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/07\/conduit-and-sarborg-advance-to-phase-ii-of-ai-driven-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/6725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=6725"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/6725\/revisions"}],"predecessor-version":[{"id":6726,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/6725\/revisions\/6726"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1142"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=6725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=6725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=6725"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=6725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}